Remix.run Logo
ckozlowski 2 hours ago

They saw a huge uptick in users during the COVID pandemic. As the corona virus is a protein shell, and their software folds protein molecules, they were able to apply it to look for targets for other molecules to attach to the virus where it would normally latch onto a cell, this could then lead to treatments.

They'd found some promising results, and were working with a pharmaceutical company to manufacture the first compounds that could then be tested. Unfortunately that company's facility was located in eastern Ukraine. =(

But that aside, they've still been going strong.

vzaliva 39 minutes ago | parent [-]

I could not find mentions of any Ukraine-based company working with them. Do you have more info?